BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15983230)

  • 21. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study.
    Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6286-90. PubMed ID: 15579791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes--a meta-analysis.
    Xu K; Zha M; Wu X; Yu Z; Yu R; Xu X; Chen H; Yang T
    Diabetes Res Clin Pract; 2011 Feb; 91(2):195-202. PubMed ID: 21131091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SNPs in PPARG associate with type 2 diabetes and interact with physical activity.
    Kilpeläinen TO; Lakka TA; Laaksonen DE; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Lindi V; Tuomilehto J; Uusitupa M; Laakso M
    Med Sci Sports Exerc; 2008 Jan; 40(1):25-33. PubMed ID: 18091023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome.
    Santer R; Groth S; Kinner M; Dombrowski A; Berry GT; Brodehl J; Leonard JV; Moses S; Norgren S; Skovby F; Schneppenheim R; Steinmann B; Schaub J
    Hum Genet; 2002 Jan; 110(1):21-9. PubMed ID: 11810292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
    Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M
    Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Kahn SE; Franks PW; Dabelea D; Hamman RF; Knowler WC; Nathan DM; Altshuler D
    Diabetes; 2007 Feb; 56(2):531-6. PubMed ID: 17259403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators--the Finnish Diabetes Prevention Study.
    Tolppanen AM; Pulkkinen L; Herder C; Koenig W; Kolehmainen M; Lindström J; Tuomilehto J; Uusitupa M;
    Genet Med; 2008 Jul; 10(7):536-44. PubMed ID: 18580688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenomodulin is associated with obesity and diabetes risk: the Finnish diabetes prevention study.
    Tolppanen AM; Pulkkinen L; Kolehmainen M; Schwab U; Lindström J; Tuomilehto J; Uusitupa M;
    Obesity (Silver Spring); 2007 May; 15(5):1082-8. PubMed ID: 17495183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study.
    Siitonen N; Pulkkinen L; Lindström J; Kolehmainen M; Schwab U; Eriksson JG; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M
    Cardiovasc Diabetol; 2011 Sep; 10():83. PubMed ID: 21943112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance.
    Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Mykkänen L; Deeb SS
    Diabetes Care; 1995 Mar; 18(3):398-400. PubMed ID: 7555485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population.
    Romeo S; Sentinelli F; Cavallo MG; Leonetti F; Fallarino M; Mariotti S; Baroni MG
    Int J Obes (Lond); 2008 Mar; 32(3):413-20. PubMed ID: 17912268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children.
    Sentinelli F; Bertoccini L; Barchetta I; Capoccia D; Incani M; Pani MG; Loche S; Angelico F; Arca M; Morini S; Manconi E; Lenzi A; Cossu E; Leonetti F; Baroni MG; Cavallo MG
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):407-13. PubMed ID: 27052925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic factors in risk assessment for the development of type 2 diabetes mellitus in a small case series.
    Abou-Hussein S; Savona-Ventura C; Grima S; Felice A
    Int J Risk Saf Med; 2011; 23(2):119-23. PubMed ID: 21673421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding protein-2, and apolipoprotein C-II) with type 2 diabetes and impaired glucose tolerance in Japanese subjects.
    Yagi T; Nishi S; Hinata S; Murakami M; Yoshimi T
    Diabet Med; 1996 Oct; 13(10):902-7. PubMed ID: 8911786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common variants in HNF-1 alpha and risk of type 2 diabetes.
    Holmkvist J; Cervin C; Lyssenko V; Winckler W; Anevski D; Cilio C; Almgren P; Berglund G; Nilsson P; Tuomi T; Lindgren CM; Altshuler D; Groop L
    Diabetologia; 2006 Dec; 49(12):2882-91. PubMed ID: 17033837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes.
    Waeber G; Delplanque J; Bonny C; Mooser V; Steinmann M; Widmann C; Maillard A; Miklossy J; Dina C; Hani EH; Vionnet N; Nicod P; Boutin P; Froguel P
    Nat Genet; 2000 Mar; 24(3):291-5. PubMed ID: 10700186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance.
    Mager U; Kolehmainen M; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto JO; Pulkkinen L; Uusitupa MI;
    Am J Hypertens; 2006 Sep; 19(9):920-6. PubMed ID: 16942934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.